SCHEMBL7305503

SCHEMBL7305503

CCn1nc(C#N)c(=O)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ ELANE P08246 3/20 0.41
▸ BCAT1 P54687 1/20 0.40
▸ F2 P00734 1/20 0.39
▸ PLAU P00749 1/20 0.39
▸ CTRB1 P17538 1/20 0.39
▸ CNR2 P34972 1/20 0.38
▸ PTGER4 P35408 1/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ P2RX4 Q99571 1/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ HRH1 P35367 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13886068 0.86 CNR2 (0.48) CNR2PDE4APDE4BPDE4CPDE4D
SCHEMBL9882815 0.78 ALDH1A1 (0.53) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL1244238 0.77 ADORA2A (0.38) ALDH1A1HSD17B10
SCHEMBL11152305 0.77 ADORA2A (0.38) ALDH1A1BCAT1MAPT
SCHEMBL9043723 0.76 ALDH1A1 (0.51) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL9041922 0.76 ALDH1A1 (0.51) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL11147011 0.76 CNR2 (0.47) ELANECNR2MAPT
SCHEMBL14518062 0.74 BCAT1 (0.63) ALDH1A1ELANEBCAT1F2PLAU
SCHEMBL9041998 0.74 ALDH1A1 (0.49) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL9042252 0.74 ALDH1A1 (0.49) ALDH1A1CNR2PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560604-B1 Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists MITSUBISHI CHEM CORP (JP) 1997-01-29 — — EP disclosed
US-5556851-A TREATMENT OF NAUSEA OR EMESIS FROM ANTICANCER DRUGS OR X-RAY TREATMENT MITSUBISHI CHEMICAL CORPORATION (JP) 1996-09-17 — — US disclosed
US-5391549-A Antagonistifc activity against serotonin 5HT3 receptors MITSUBISHI KASEI CORPORATION (JP) 1995-02-21 — — US disclosed
EP-0560604-A1 Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists Mitsubishi Chemical Corporation (JP) 1993-09-15 — — EP disclosed
Send feedback